Illumina Inc (ILMN)

Illumina, Inc. is a common stock listing on NASDAQ for a healthcare company focused on sequencing- and array-based technologies for genetic and genomic analysis. Its product portfolio includes sequencing and array instruments, consumables such as reagents, flow cells, and library preparation materials, as well as whole-genome sequencing and targeted resequencing kits. The company also provides services including whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support. Illumina serves customers across the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa, with end users that include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical and biotechnology companies, molecular diagnostic laboratories, and consumer genomics firms. Incorporated in 1998 and based in San Diego, California, the company sells directly to customers and through life-science distributors.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.